Literature DB >> 22336724

Systemic administration of autologous adipose-derived mesenchymal stem cells alleviates hepatic ischemia-reperfusion injury in rats.

Cheuk-Kwan Sun1, Chia-Lo Chang, Yu-Chun Lin, Ying-Hsien Kao, Li-Teh Chang, Chia-Hung Yen, Pei-Lin Shao, Chih-Hung Chen, Steve Leu, Hon-Kan Yip.   

Abstract

OBJECTIVES: Mesenchymal stem cells have previously been shown to offer significant therapeutic benefit in ischemic organ injuries. This study aimed at investigating the therapeutic role of adipose tissue-derived mesenchymal stem cells in hepatic ischemia-reperfusion injury and the underlying mechanisms.
DESIGN: Adult male Fisher rats (n = 30) were equally divided into three groups (group 1: Sham-operated normal controls; group 2: Ischemia-reperfusion injury with intravenous fresh culture medium; group 3: Ischemia-reperfusion injury with intravenous adipose tissue-derived mesenchymal stem cells). Ischemia-reperfusion injury was induced by occluding the vascular supplies of left lobe liver for 60 minutes followed by reperfusion for 72 hrs. Adipose tissue-derived mesenchymal stem cells (1.2 × 106) were administered through tail vein immediately after reperfusion and at 6 hrs and 24 hrs after reperfusion in group 3. All animals were sacrificed 72 hrs after reperfusion.
SETTING: Animal laboratory at a medical institute.
MEASUREMENTS AND MAIN RESULTS: Histologic features, plasma aspartate aminotransferase, hepatic cytokine profile, oxidative stress, and terminal deoxynucleotidyltransferase-mediated dUTP nick end labeling were analyzed. Seventy-two hrs after reperfusion, plasma aspartate aminotransferase, hepatic oxidative stress, messenger RNA expressions of tumor necrosis factor-a, transforming growth factor-b, interleukin-1b, interleukin-6, endothelin-1, matrix metalloproteinase-9, plasminogen activator inhibitor-1, Bax and caspase-3, protein expression of intercellular adhesion molecule as well as the number of apoptotic nuclei were significantly increased in group 2 compared with group 3, whereas messenger RNA expressions of endothelial nitric oxide synthase, Bcl-2, interleukin-10, protein expressions of reduced nicotinamide-adenine dinucleotide phosphate:quinone oxidoreductase 1, and heme oxygenase-1 were lower in group 2 than group 3.
CONCLUSIONS: The results showed that systemic adipose tissue-derived mesenchymal stem cell administration significantly preserved hepatocyte integrity and suppressed inflammatory responses, oxidative stress, and apoptosis in a rodent model of hepatic ischemia-reperfusion injury.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22336724     DOI: 10.1097/CCM.0b013e31823dae23

Source DB:  PubMed          Journal:  Crit Care Med        ISSN: 0090-3493            Impact factor:   7.598


  18 in total

1.  Extracellular vesicles from bone marrow-derived mesenchymal stem cells protect against murine hepatic ischemia/reperfusion injury.

Authors:  Hiroaki Haga; Irene K Yan; David A Borrelli; Akiko Matsuda; Mansi Parasramka; Neha Shukla; David D Lee; Tushar Patel
Journal:  Liver Transpl       Date:  2017-06       Impact factor: 5.799

Review 2.  Mesenchymal stem cell-based tumor-targeted gene therapy in gastrointestinal cancer.

Authors:  Qi Bao; Yue Zhao; Hanno Niess; Claudius Conrad; Bettina Schwarz; Karl-Walter Jauch; Ralf Huss; Peter J Nelson; Christiane J Bruns
Journal:  Stem Cells Dev       Date:  2012-06-26       Impact factor: 3.272

Review 3.  Rationale for the potential use of mesenchymal stromal cells in liver transplantation.

Authors:  Morgan Vandermeulen; Céline Grégoire; Alexandra Briquet; Chantal Lechanteur; Yves Beguin; Olivier Detry
Journal:  World J Gastroenterol       Date:  2014-11-28       Impact factor: 5.742

Review 4.  Cell-based therapy for acute organ injury: preclinical evidence and ongoing clinical trials using mesenchymal stem cells.

Authors:  Antoine Monsel; Ying-Gang Zhu; Stephane Gennai; Qi Hao; Jia Liu; Jae W Lee
Journal:  Anesthesiology       Date:  2014-11       Impact factor: 7.892

5.  Therapeutic effect of placenta-derived mesenchymal stem cells on hypoxic-ischemic brain damage in rats.

Authors:  Hong-Fang Ding; Hui Zhang; Hui-Fang Ding; Dong Li; Xin-Hao Yi; Xin-Yi Gao; Wei-Wei Mou; Xiu-Li Ju
Journal:  World J Pediatr       Date:  2014-12-01       Impact factor: 2.764

6.  Melatonin treatment enhances therapeutic effects of exosomes against acute liver ischemia-reperfusion injury.

Authors:  Cheuk-Kwan Sun; Chih-Hung Chen; Chia-Lo Chang; Hsin-Ju Chiang; Pei-Hsun Sung; Kuan-Hung Chen; Yi-Ling Chen; Sheng-Yi Chen; Gour-Shenq Kao; Hsueh-Wen Chang; Mel S Lee; Hon-Kan Yip
Journal:  Am J Transl Res       Date:  2017-04-15       Impact factor: 4.060

Review 7.  Therapeutic potential of mesenchymal stem cells for oral and systemic diseases.

Authors:  Reuben H Kim; Shebli Mehrazarin; Mo K Kang
Journal:  Dent Clin North Am       Date:  2012-07

8.  Adipose derived mesenchymal stem cells transplantation via portal vein improves microcirculation and ameliorates liver fibrosis induced by CCl4 in rats.

Authors:  Yu Wang; Fan Lian; Jiaping Li; Wenzhe Fan; Hanshi Xu; Xiuyan Yang; Liuqin Liang; Wei Chen; Jianyong Yang
Journal:  J Transl Med       Date:  2012-06-26       Impact factor: 5.531

Review 9.  Using adipose-derived mesenchymal stem cells to fight the metabolic complications of obesity: Where do we stand?

Authors:  Agnieszka Mikłosz; Barbara Emilia Nikitiuk; Adrian Chabowski
Journal:  Obes Rev       Date:  2022-01-05       Impact factor: 10.867

10.  Human adipose tissue derived mesenchymal stem cells aggravate chronic cyclosporin nephrotoxicity by the induction of oxidative stress.

Authors:  Byung Ha Chung; Sun Woo Lim; Kyoung Chan Doh; Shang Guo Piao; Seong Beom Heo; Chul Woo Yang
Journal:  PLoS One       Date:  2013-03-26       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.